Machine learning in medicine: Part three

Machine Learning in Medicine: Part Three

Volumn 9789400778696, Issue , 2013, Pages 1-224

  Cleophas, Ton J ^a,c   Zwinderman, Aeilko H ^b,c  

^a ALBERT SCHWEITZER HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c Pharmaceutical Medicine   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BAYESIAN NETWORKS; COMPUTER PROGRAMMING; DECISION TREES; DISCRIMINANT ANALYSIS; FUZZY NEURAL NETWORKS; KNOWLEDGE BASED SYSTEMS; LEAST SQUARES APPROXIMATIONS; NEWTON-RAPHSON METHOD; STOCHASTIC SYSTEMS;

ANOMALY DETECTION; CANONICAL ANALYSIS; CORRESPONDENCE ANALYSIS; DISCRETE WAVELET ANALYSIS; MACHINE LEARNING METHODS; PARTIAL LEAST SQUARE (PLS); STEP-BY-STEP ANALYSIS; STOCHASTIC METHODS;

LEARNING SYSTEMS;

EID: 84931308145     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-94-007-7869-6     Document Type: Book

References (184)

1. Vinterbo S, Ohno L (1999) A genetic algorithm to select variables in logistic regression: Example in the domain of myocardial infarction. In: Proceedings of the AMIA (American Medical Information Association) symposium 1999, Washington, DC, USA, pp 984-988.
2. SPSS Statistical Software (2013) www.spss.com. 09 Aug 2013.
3. STATA Statistical Software (2013) www.stata.com. 09 Aug 2013.
4. Akbari R, Ziarati K (2011) A multilevel evolutionary algorithm for optimizing numerical functions. Int J Ind Eng Comput 2:419-430.
5. R Package Subselect (2013) www.r-statistics.com. 16 Aug 2013.
6. Radonic T, de Witte P, Groenink M, de Waard V, Lutter R, van Eijk M, Jansen M, Timmermans J, Kempers M, Scholte AJ, Hilhorst-Hofstee Y, van den Berg MP, Van Tintelen JP, Pals G, Baars MJ, Mulder BJ, Zwinderman AH (2012) Inflammation aggravates disease severity in Marfan syndrome patients. PLoS One 7:e32963.
7. Vinterbo S, Ohno L (1999) A genetic algorithm to select variables in logistic regression: Example in the domain of myocardial infarction. In: Proceedings of the AMIA (American Medical Information Association) symposium, Washington DC, USA, pp 984-988.
8. Cleophas TJ, Zwinderman AH (2013) Hierarchical cluster analysis for unsupervised data. In: Cleophas TJ, Zwinderman AH (eds) Machine learning in medicine. Springer, Heidelberg, pp 183-195.
9. Cleophas TJ, Zwinderman AH (2013) Artificial intelligence, multilayer perceptron modeling. In: Cleophas TJ, Zwinderman AH (eds) Machine learning in medicine. Springer, Heidelberg, pp 145-154.
10. Cleophas TJ, Zwinderman AH (2013) Factor analysis. In: Cleophas TJ, Zwinderman AH (eds) Machine learning in medicine. Springer, Heidelberg, pp 167-181.
11. Cleophas TJ, Zwinderman AH (2013) Bayesian networks. In: Cleophas TJ, Zwinderman AH (eds) Machine learning in medicine, part two. Springer, Heidelberg, pp 163-170.
12. Cleophas TJ, Zwinderman AH (2013) Support vector machines. In: Cleophas TJ, Zwinderman AH (eds) Machine learning in medicine, part two. Springer, Heidelberg, pp 155-161.
13. Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B (1998) Effect of SSRI antidepressants on ejaculation: A double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol 18:274-281.
14. Anonymous (1999) Multiple comparisons book. Edition University of Leiden, Leiden.
15. SAS Statistical Software (2013) www.sas.com. 17 June 2013.
16. SPSS Statistical Software (2013) www.spss.com. 17 June 2013.
17. Cleophas TJ, Zwinderman AH (2012) Discriminant analysis. In: Cleophas TJ, Zwinderman AH (eds) Machine learning in medicine part one. Springer, Heidelberg, pp 215-224.
18. Cleophas TJ, Zwinderman AH (2012) Partial least squares. In: Cleophas TJ, Zwinderman AH (eds) Machine learning in medicine part one. Springer, Heidelberg, pp 197-212.
19. Hochberg Y (1988) A sharper Bonferroni procedure for multiple tests of significance. Biometrika 75:800-802.
20. Fuchs HA (1993) The use of the disease activity score in the analysis of clinical trials in rheumatoid arthritis. J Rheumatol 20:1863-1866.
21. Lauter J (1996) Exact t and F-tests for analyzing studies with multiple endpoints. Biometrics 52:964-970.
22. Jukema JW, Bruschke AV, Van Boven AJ, Zwinderman AH et al (1995) Effects of lipid lowering by pravastatin on the regression of coronary artery disease in symptomatic men. Circulation 91:2528-2540.
23. Cleophas TJ, Zwinderman AH (2012) Canonical regression. In: Cleophas TJ, Zwinderman AH (eds) Machine in medicine part one. Springer, Heidelberg, pp 225-240.
24. SPSS Statistical Software (2013) www.spss.com. 7 Aug 2013.
25. Fayyad U, Irani K (1993) Multi-interval discretization of continuous value attributes for classification learning. In: 13th International joint conference of machine learning, Los Altos.
26. SPSS Statistical Software (2013) www.spss.com. 5 June 2013.
27. Vichare NM, Rodgers P, Pecht MG (2013) Methods for binning and density estimates of load parameters for prognostics and health management. www.prognodics.umd.edu. 5 June 2013.
28. Sepulveda MJ, Lu C, Sill S, Young J, Edington D (2010) An observational study of an employer intervention for children's healthy weight behaviors. Pediatrics 126:e1153-e1160.
29. SAS Statistical Software (2013) www.sas.com. 2 Sept 2013.
30. SPSS Statistical Software (2013) www.spss.com. 2 Sept 2013.
31. S-plus Statistical Software (2013) www.splus.com. 2 Sept 2013.
32. Stata Statistical Software (2013) www.stata.com. 2 Sept 2013.
33. P Value Calculator (2013) http://Graphpad.com/quickcalcs/PValue.1.cfm. 30 June 2013.
34. Z Score to P Value Calculator (2013) Easycalculation.com>Statistics. 30 June 2013.
35. Free p-Value Calculation for an F-test (2013) www.danielsoper.com>StatisticsCalculators. 30 June 2013.
36. Levin RI, Rubin DS (1998) P-value. In: Levin RI, Rubin DS (eds) Statistics for management. Prentice-Hall, Upper Saddle River, NJ, USA, pp 485-496.
37. Utts JM (1999) P-value. In: Utts JM (ed) Seeing through statistics. Duxbury Press, Detroit, pp 375-386.
38. Cleophas TJ, Zwinderman AH, Cleophas AF (2004) P-values. Review. Am J Ther 11:317-322.
39. Cleophas TJ, Zwinderman AH, Cleophas AF (2004) P-values, beware of the extremes. Clin Chem Lab Med 42:300-305.
40. Michelson S, Schofield T (1996) P-values as conditional probabilities. In: Michelson S, Schofield T (eds) The biostatistics cookbook. Kluwer Academic Publishers, Boston, pp 46-58.
41. Petrie A, Sabin C (2000) Explanation of p-values. In: Petrie A, Sabin C (eds) Medical statistics at glance. Blackwell Science, Oxford, pp 42-45.
42. Matthews DE, Farewel VT (1996) P-value. In: Matthews DE, Farewell VT (eds) Using and understanding medical statistics. Karger, New York, pp 15-18.
43. Riffenburgh RH (1999) P-values. In: Riffenburgh RH (ed) Statistics in medicine. Academic Press, San Diego, pp 95-96, 105-106.
44. Cleophas TJ, Cleophas GM (2001) Sponsored research and continuing medical education. JAMA 286:302-304.
45. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S et al, for the HOT Study Group (1998) Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351:1755-1762.
46. Sandham JD, Hull RD, Brand RF, Knox L, Pineo GF, Doig CJ et al, for the Canadian Critical Care Clinical Trials Group (2003) A randomized, controlled trial of the use of pulmonaryartery catheters in high-risk surgical patients. N Engl J Med 348:5-14.
47. LIPID Study Group (2002) Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: The LIPID trial follow-up. Lancet 359:1379-1387.
48. Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: A randomised placebocontrolled trial. Lancet 360:7-22.
49. Parisi AF, Folland ED, Hartigan P, on behalf of the Veterans Affairs ACME Investigators (1992) A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 326:10-16.
50. Seppäla H, Nissinen A, Järvinen H, Huovinen S, Henrikson T, Herva E et al (1992) Resistance to erythromycin in group A streptococci. N Engl J Med 326:292-297.
51. Rafal ES, Griffiths CE, Ditre CM, Finkel LJ, Hamilton TA, Ellis CN et al (1992) Topical retinoin treatment for liver spots associated with photodamage. N Engl J Med 326:368-374.
52. Barrett BJ, Parfrey PS, Vavasour HM, O'Dea F, Kent G, Stone E (1992) A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization. N Engl J Med 326:431-436.
53. Medical Research Council (1948) Streptomycin treatment of pulmonary tuberculosis. Br Med J 2:769-782.
54. Motulsky H (1995) P-values, definition and common misinterpretations. In: Motulsky H (ed) Intuitive biostatistics. Oxford University Press, New York, pp 96-97.
55. Cleophas TJ, Zwinderman AH (2012) Multivariate analysis, chapter 25. In: Cleophas TJ, Zwinderman AH (eds) Statistics applied to clinical studies, 5th edn. Springer, Heidelberg, pp 289-299.
56. Hagle T (2014) Probit analysis. In: Lewis-Beck MS, Bryman A, Liao's TF (eds) SAGE encyclopedia of social sciences. SAGE, New York, pp 710-720. doi:10.4135/97814122950589.
57. SPSS Statistical Software (2013) www.spss.com. 2 Sept 2013.
58. STATA Statistical Software (2013) www.stata.com. 2 Sept 2013.
59. Anonymous (2013) Overdispersion. At Planet Math. http://planetmath.org/encyclopedia/Overdispersion.html. 26 June 2013.
60. Cleophas TJ, Zwinderman AH (2012) Data dispersion issues. In: Cleophas TJ, Zwinderman AH (eds) Statistics applied to clinical studies, 5th edn. Springer, Heidelberg, pp 149-159.
61. Fisher R (1953) Dispersion on a sphere. Proc R Soc Lond 217:295-305.
62. Tan M (2003) Describing data, variability, and overdispersion in medical research. In: Fang J (ed) Advanced medical statistics. World Scientific, River Edge, pp 319-332.
63. Hojsgaard S, Halekoh U (2005) Overdispersion. Danish Institute of Agricultural Sciences, Copenhagen, 1 June. http://gbi.agrsci.dk/statistics/courses. 26 June 2013.
64. SPSS Statistical Software (2013) www.spss.com. 26 June 2013.
65. Anonymous (2013) Gauss summary. www-groups.dcs.st-and.ac.uk/history/Mathematicians/Gauss.html. 26 June 2013.
66. Cleophas TJ, Zwinderman AH (2012) Testing clinical trials for randomness. In: Cleophas TJ, Zwinderman AH (eds) Statistics applied to clinical studies, 5th edn. Springer, Heidelberg, pp 469-478.
67. Cleophas TJ, Zwinderman AH (2012) Poisson regression. In: Cleophas TJ, Zwinderman AH (eds) SPSS for starters part two. Springer, Heidelberg, pp 43-48.
68. Anonymous (2006) Distinguishing between random and fixed variables, effects and coefficients. Newson, USP 656 Winter 2006, pp 1-3.
69. Campbell MJ (2006) Random effects models. In: Campbell MJ (ed) Statistics at square two, 2nd edn. Blackwell Publishing/BMJ Books, Oxford, pp 67-83.
70. Gao S (2003) Special models for sampling survey. In: Lu Y, Fang J (eds) Advanced medical statistics, 1st edn. World Scientific, River Edge, pp 685-709.
71. Anonymous (2013) Variance components and mixed models. http://www.statsoft.com/textbook/stvarcom.html. 9 Feb 2013.
72. Anonymous (2013) Random effects models. Wikipedia, the free encyclopedia. http://en.wikipedia.org/wiki/random-effects-models.html. 9 Feb 2013.
73. Brier ME, Aronoff GR (1996) Application of artificial neural networks to clinical pharmacology. Int J Clin Pharmacol Ther 34:510-514.
74. Dalla Costa, T, Nolting A, Rand K, Derendorf H (1997) Pharmacokinetic -pharmacodynamic modelling of the in vitro antiinfective effect of piperacillin -tazobactam combinations. Int J Clin Pharmacol Ther 35:426-433.
75. Mahmood I (2003) Center specificity in the limited sampling model (LSM): can the LSM developed from healthy subjects be extended to disease states? Int J Clin Pharmacol Ther 41:517-523.
76. Meibohm B, Derendorf H (1997) Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling. Int J Clin Pharmacol Ther 35:401-413.
77. Lima JJ, Beasley BN, Parker RB, Johnson JA (2005) A pharmacodynamic model of the effects of controlled-onset extended-release verapamil on 24-hour ambulatory blood pressure. Int J Clin Pharmacol Ther 43:187-194.
78. Lotsch J, Kobal G, Geisslinger G (2004) Programming of a flexible computer simulation to visualize pharmacokinetic-pharmacodynamic models. Int J Clin Pharmacol Ther 42:15-22.
79. Mueck W, Becka M, Kubitza D, Voith B, Zuehlsdorf M (2007) Population model of the pharmacokinetics and pharmacodynamics of rivaroxaban-an oral, direct factor xa inhibitor-in healthy subjects. Int J Clin Pharmacol Ther 45:335-344.
80. Cleophas TJ, Zwinderman AH (2011) Interaction, chapter 18. In: Cleophas TJ, Zwinderman AH (eds) Statistical analysis of clinical data on a pocket calculator. Springer, Heidelberg, pp 49-51.
81. SPSS Statistical Software (2013) http://www.spss.com. 9 Feb 2013.
82. Anonymous (2013) Weighted least squares. www.itl.nist.gov/div898/handbook. 9 June 2013.
83. Anonymous (2009) Extending linear regression: Weighted least squares, heteroscedasticity, local polynomial regression. 36-350 Data Mining. 23 Oct 2009. Pittsburgh, PA, USA, www.stat.cmu. edu. 9 June 2013.
84. Nievergelt Y (2000) A tutorial history of least squares. J Comput Appl Math 121:37-72.
85. SPSS Statistical Software (2013) www.spss.com. 9 June 2013.
86. Ferreira J, Vasconcelos F, Tierra-Criollo C (2011) A case study of applying weighted least squares to calibrate a digital maximum respiratory pressures measuring system. In: Applied biomedical engineering. John Hopkins University, Baltimore.
87. Fessler J (1994) Penalized weighted least squares image reconstruction for PET. IEEE Trans Med Imaging 13:290-299.
88. Brookhart MA, Rothman KJ (2008) Simple estimators of the intensity of seasonal occurrence of monocytic leucemia. BMC Med Res Methodol 8:67-71.
89. Anonymous (2013) Corporate history-SPSS. www.spss.com. 6 Jan 2013.
90. Hox J (2002) Multilevel analysis, techniques and applications. LEA Publishers, Mahwah.
91. Anonymous (1988) Statistical methods for analyzing a complex sample survey. Public Health Service, Centers of Disease Control, National Center for Health Statistics, Ed by National Institute of Health, Washington, DC.
92. Lee ES, Forthofer RN (2006) Analyzing complex survey data, 2nd edn. www.sagepub.com. 24 Apr 2013.
93. Rafferty A (2013) Introduction to complex sample design in UK Government Surveys. ESDS (Economic and Social Data Service) Government web site. www.esds.ac.uk/government. 24 Apr 2013.
94. Cochran WG (1953) Sampling techniques. John Wiley & Sons, New York.
95. SPSS Statistical Software (2013) www.spss.com. 20 Apr 2013.
96. Ware JE (1987) Standards for health measures. J Chron Dis 40:473-478.
97. Bradley JV (1968) Chapter 12, The runs test. In: Distribution-free statistical concepts. Prentice Hall Inc., Englewood Cliffs.
98. Anonymous (2013) Runs test for detecting non-randomness. www.itl.nist.gov.div898/handbook/eda/section3/eda35d.htm. 3 June 2013.
99. Maddux CD (2012) SPSS for windows-the runs test for randomness. http://wolfweb.unr.edu/homepage/maddux/stat/cep741/runwin.html. 3 June 2012.
100. Cleophas TJ, Zwinderman AH (2013) Chapter 14, Multivariate analysis of time-series. In: Cleophas TJ, Zwinderman AH (eds) Machine learning part two. Springer, Heidelberg.
101. Cleophas TJ, Zwinderman AH (2012) Chapter 15, Curvilinear estimation. In: Cleophas TJ, Zwinderman AH (eds) SPSS for starters part 2. Springer, Heidelberg.
102. SPSS Statistical Software (2013) www.spss.com. 3 June 2013.
103. Anonymous (2013) Wald-Wolfowitz test. http://en.wikipedia.org.wiki/Wald%E2%80%93Wolfowitz-runs-test. 4 June 2013.
104. Cleophas TJ, Zwinderman AH (2011) Chapter 42, Testing clinical trials for randomness. In: Cleophas TJ, Zwinderman AH (eds) Statistics applied to clinical research, 5th edn. Springer, Heidelberg, pp 469-478.
105. Cleophas TJ, Zwinderman AH (2012) Linear regression. In: Cleophas TJ, Zwinderman AH (eds) Statistics applied to clinical studies, 5th edn. Springer, Heidelberg, pp 199-203.
106. Shannon CE (1951) Prediction and entropy of printed English. Bell Syst Tech J 30:50-64.
107. Quinlan R (1999) Data mining from an A1 perspective. Data engineering 1999. In: Proceedings of the 15th international conference of data engineering, Sydney, Australia, p 186.
108. Perlich C, Provost F, Simonoff JS (2003) Tree induction versus logistic regression. J Mach Learn 4:211-255.
109. Babic S, Kokol P, Stiglic M (2000) Fuzzy decision trees in the support of breastfeeding. In: Proceedings 13th IEEE symposium on computer-based medical systems CBMS, Houston, pp 7-11.
110. Zhang H, Legro R, Zhang J, Zhang L, Chen X, Huang H, Casson P, Schlaff W, Diamond M, Krawetz S, Coutifaris C, Brzyski R, Christman G, Santoro N, Eisenberg E, for the Reproductive Network (2010) Decision trees for identifying predictors of treatment effectiveness in clinical trials and its applications to ovulation in a study of women with polycystic ovary syndrome. Hum Reprod 25:2612-2621.
111. Sims C, Meyn L, Caruana R, Rao R, Mitchell T, Krohn M (2000) Predicting caesarean delivery with decision tree models. Am J Obstet Gynecol 183:1198-1206.
112. Tsien C, Kohane L, McIntosh N (2000) Multiple signal integration by decision tree induction to detect artifacts in the neonatal intensive care unit. Artif Intell Med 19:189-202.
113. Sanders G, Hagerty C, Sonnenberg F, Hlatkey M, Owens D (2000) Distributed decision support using a web-based interface: Prevention of sudden cardiac death. Med Decis Mak 19:157-166.
114. Tsien C, Fraser H, Long W, Kennedy R (1998) Using classification tree and logistic methods to diagnose myocardial infarction. In: Proceedings 9th World Congress on Medical Informatics. MEDINFO'98, vol 52, Amsterdam, pp 493-497.
115. Bonner G (2001) Decision making for health care professionals: use of decision trees within the community mental health setting. J Adv Nurs 35:349-356.
116. Dantchev N (1996) Therapeutic decision trees in psychiatry. Encephale Revue de Psychiatrie Clinique Biologique et Therapeutique 22:205-214.
117. Gambhir S (1999) Decision analysis in nuclear medicine. J Nucl Med 10:1570-1581.
118. Jones J (2001) The role of data mining technology in the identification of signals of possible adverse drug reactions. Curr Ther Res 62:664-672.
119. Ohno-Machado L, Lacson R, Massad E (2000) Decision trees and fuzzy logic: A comparison of models for the selection of measles vaccination strategies in Brazil. J Am Med Inform Assoc 9:625-629.
120. Kokol P, Zorman M, Stiglic M, Malcic L (1998) The limitations of decision trees and automatic learning in real world medical decision making. In: Proceedings 9th World Congress on Medical Informatics. MEDINFO'98, vol 52, Amsterdam, pp 529-533.
121. Letourneau S, Jensen L (1998) Impact of a decision tree on chronic wound care. Wound Ostomy Continence Nurs 25:240-247.
122. Odgorelec V, Kokol P, Stiglic B, Rozman I (2002) Decision trees, an overview and their use in medicine. J Med Syst 26:445-463.
123. SPSS Statistical Software (2013) www.spss.com. 15 July 2013.
124. Anonymous (2011) Creating decision trees. BM Corporation, Armonk.
125. Cleophas TJ, Zwinderman AH (2012) Binary partitioning. In: Cleophas TJ, Zwinderman AH (eds) Machine learning in medicine. Springer, Heidelberg, pp 79-86.
126. Breiman L, Frieman JH, Olsen RA, Stone CJ (1984) Classification and regression trees. Chapman & Hall (Wadsworth Inc.), New York.
127. Cleophas TJ, Zwinderman AH (2012) The limitations of linear regression. In: Cleophas TJ, Zwinderman AH (eds) Statistics applied to clinical studies, 5th edn. Springer, Heidelberg, p 176.
128. Breiman L (2001) Random forests. Department of Statistics, University of California, Berkeley.
129. Cleophas TJ, Zwinderman AH (2012) Seasonality assessments. In: Cleophas TJ, Zwinderman AH (eds) Machine learning in medicine. Springer, Heidelberg, pp 113-126.
130. Schuster A (1898) On the investigation of hidden periodicities with application to a supposed 26 day period of meteorological phenomena. Terr Magnet 3:13-41.
131. Box G, Jenkins G (1970) Time series analysis: forecasting and control. Holden-Day, San Francisco.
132. SPSS Statistical Software (2013) www.spss.com. 17 July 2013.
133. Kramarenko A, Tan U (2002) Validity of spectral analysis of evoked potentials in brain research. Int J Neurosci 112:489-499.
134. Sanders P, Berenfeld O, Hocini M, Jais P, Vaidyanathan R, Hsu L, Garrigue S, Takahashi Y, Rotter M, Sacher F, Scavee C, Ploutz R, Jalife J, Haissaguerre M (2005) Spectral analysis identifies sites of high frequency activity maintaining atrial fibrillation in humans. Circulation 112:789-797.
135. Motulsky HJ, Ransna LA (1987) Fitting curves to data using nonlinear regression: A practical and nonmathematical review. FASEB J 1:365-374.
136. Newton I (1711) De analysi per aequationes numero terminorum infinitas. William Jones, London.
137. Marquardt D (1963) An algorithm for least-squares estimation of non-linear parameters. SIAM J Appl Math 11:431-441.
138. SPSS Statistical Software (2013) www.spss.com. 10 Apr 2013.
139. Excel (2013) www.excel.nl. 15 Apr 2013.
140. Anonymous (2013) Applications of nonlinear least squares regression to ground-water flow modeling, West Central Florida, US Geological Society report 00-4094. fl.water.usgs.gov/PDF. 10 Apr 2013.
141. Le Botlan, D, Rugraff Y, Ouguerzan L (1996) 180o Pulse imperfection effects on fitting of relaxation curves obtained by low field NMR spectroscopy. Spectrosc Lett 29:1091-1102.
142. De Diego, A, Madariago J, Chapola E (1997) Effect of additional hydrofluoric acid on the conductivity of concentrated fluorosilicic acid aquous solutions. J Chem Eng Data 42:209-213.
143. Corley R, Murphy M (2004) An in vitro technique for measuring the production rate of volatile fatty acids in the rumes under dynamic conditions. Small Rum Res 54:219-225.
144. Utomo HD, Hunter KA (2010) Particle concentration adsorption of divalent metal ions on coffee grounds. Bioresour Technol 101:1482-1486.
145. Maddala CS (2008) Nonlinear least squares regression. In: Introduction to econometrics, 3rd edn. Wiley, New York.
146. Chen J, Wu H (2008) Efficient local estimation for time-varying coefficients in deterministic dynamic models with application to HIV-dynamics. J Am Stat Assoc 103:369-383.
147. Yang G, Hipwell JH, Hawkes DJ, Arridge SR (2012) A nonlinear least squares model for solving the joint reconstruction and registration problem of digital breast tomosynthesis. In: Proceedings of medical image understanding and analysis. Department of Computer Science, Swansea University, Swansea, pp 87-92.
148. Kemmer G, Keller S (2010) Nonlinear least-squares data fitting in excel spreadsheets. Nat Protoc 5:267-281.
149. Online nonlinear regression (2013) http://www.xuru.org/rt/NLR.asp. 4 Sept 2013.
150. Brody TM (1994) Concentration-response relationships. In: Brody TM, Larner J, Minneman KP, Neu HC (eds) Human pharmacology, 2nd edn. Mosby, St. Louis, pp 25-32.
151. Boeckman AJ, Sheiner LB, Beal SL (1992) NONMEM user's guide of the NONMEM Project Group, University California, San Francisco.
152. Markov AA (1971) Extension of the limit theorem of probability theory to a sum of variables connected in a chain. In: Howard RA (ed) Dynamic probabilistic systems, vol 1: Markov Chains. Wiley, London.
153. Brindle P, Emberson J, Lampe F (2003) Predictive accuracy of the Framingham coronary risk score in British men. BMJ 327:1267-1273.
154. Durrett R (2010) Probability, theory and examples. Cambridge University Press, Cambridge.
155. Fang J, Caixia L (2003) Stochastic processes and their applications in medical science. In: Lu Y, Fang JQ (eds) Advanced medical statistics. World Scientific, River Edge.
156. Anonymous (2013) Hardy-Weinberg principle. Wikipedia.org/wiki/Hardy%E2%89%93Wein berg-principle. 8 May 2013.
157. Online Matrix Calculator-Bluebit Software (2013) www.bluebit.gr/matrix-c. 8 May 2013.
158. Ward P (2008) The future of mankind - how will evolution change humans. Scientific American, New York, NY, USA, 7 December.
159. Anonymous (2013) Markov Chains, think about it. Addison Wesley product. Pearson Education Inc. www.pearsoned.com. 29 May 2013.
160. Markov AA (1971) Extension of the limit theorem of probability theory to a sum of variables connected in a chain. In: Howard R (ed) Dynamic probabilistic systems, vol 1: Markov Chains, Wiley, London.
161. Mentch L (2013) Absorbing Markov chains. www.facstaff.bucknell.edu/ap030/Math3451. 30 May 2013.
162. Brindle P, Emberson J, Lampe F (2003) Predictive accuracy of the Framingham coronary risk score in British men. BMJ 327:1267-1273.
163. Durrett R (2010) Probability, theory and examples. Cambridge University Press, Cambridge.
164. Fang J, Caixia L (2003) Stochastic processes and their applications in medical science. Chapter 26. In: Lu Y, Fang JQ (eds) Advanced medical statistics. World Scientific, River Edge, pp 991-1032.
165. Grinstead CM, Snell JL (1997) Introduction to probability. AMS Bookstore, Philadelphia.
166. Online Matrix Calculator - Bluebit Software (2013) www.bluebit.gr/matrix-c. 8 May 2013.
167. Ward P (2008) The future of mankind-how will evolution change humans. Scientific American, 7 December.
168. Ireland G (2013) An idea that changed the world. Harvard Gazette, the official organ of the Harvard University, Cambridge, 29 May 2013, pp 1-5.
169. Sonnenberg FA, Beck JB (1993) Markov models in medical decision making: A practical guide. Med Decis Making 13:322-328.
170. Hazen G (2012)Markov versusmedical Markov modeling. Powerpoint presentation. Northwestern University, Chicago, February 2012.
171. Bartolomeo N, Trerotoli P, Moretti A, Serio G (2008) A Markov model to evaluate hospital readmission. BMC Res Methodol 8:23-26.
172. Liu CH, Wang KM, Guh YY (1991) A Markov chain model for medical record analysis. J Oper Res Soc 42:357-364.
173. Kupinski MA, Hoppin JW, Clarkson E, Barrett HH (2003) Ideal-observer computation in medical imaging with use of Markov chain Monte Carlo techniques. J Oper Soc Am Opt Image Sci Vis 20:430-438.
174. Zipkin EF, Christopher SJ, Cooch EG (2010) A primer on the application of Markov chains to the study of wildlife disease dynamics. Meth Ecol Evol 1:192-198.
175. Green PE, Srinivasan V (1978) Conjoint analysis in consumer research: issues and outlook. J Consum Res 5:1023-1033.
176. Cleophas TJ, Zwinderman AH (2013) Chapter 14 Factor analysis. In: Cleophas TJ, Zwinderman AH (eds) Machine learning in medicine part one. Springer, Heidelberg, pp 167-181.
177. Cleophas TJ, Zwinderman AH (2013) Chapter 16 Partial least squares. In: Cleophas TJ, Zwinderman AH (eds) Machine learning in medicine part one. Springer, Heidelberg, pp 197-212.
178. Cleophas TJ, Zwinderman AH (2013) Discriminant analysis. In: Cleophas TJ, Zwinderman AH (eds) Machine learning in medicine part one. Springer, Heidelberg, pp 215-224.
179. Gustaffson A, Hermann A, Huber F (2001) Conjoint analysis as an instrument of market research practice. In: Conjoint measurement: Methods and applications. Springer, Heidelberg, pp 5-46.
180. Furlan R, Corradetti R (2006) Aspects of experimental design in the prescription-based conjoint analysis model. In: Sixth proceedings of ENBIS (European Network of Business and Industrial Statistics), Wroclaw, Poland.
181. Anonymous (2013) Conjoint analysis (healthcare). http://en.wikipedia.org/Conjoint-analysis-healthcare. 7 July 2013.
182. SPSS Statistical Software (2013) www.spss.com. 7 July 2013.
183. Atiqi R, Cleophas TJ, Van Bommel E, Zwinderman AH (2010) Prevalence of iatrogenic admissions to the departments of medicine/cardiology/pulmonology in a 1250 beds general hospital. Int J Clin Pharmacol Ther 48:517-521.
184. SPSS Statistical Software (2013) www.spss.com. 2 Sept 2013.